SPOT-008 Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukaemia cells from apoptosis
Sign Up to like & getrecommendations! Published in 2018 at "ESMO Open"
DOI: 10.1136/esmoopen-2018-eacr25.41
Abstract: Introduction B-cell chronic lymphocytic leukaemia (B-CLL) cells are resistant to apoptosis, and consequently accumulate to the detriment of normal B cells and patient immunity. Because current therapies fail to eradicate these apoptosis-resistant cells, it is… read more here.
Keywords: cll; cll cells; interaction; receptor ... See more keywords
Visceral Leishmaniasis Associated with B-Cell Chronic Lymphocytic Leukemia: Report of a Case and Review of the Literature
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12020185
Abstract: Infections often complicate the course of hematological diseases and may represent a diagnostic challenge. In particular, visceral leishmaniasis diagnosis may be missed in lymphoma patients, as lymphoma-related immunosuppression can lead to a misleadingly negative Leishmania… read more here.
Keywords: visceral leishmaniasis; serology; cell chronic; chronic lymphocytic ... See more keywords
B-cell chronic lymphocytic leukemia followed by mycosis fungoides in a psoriatic patient on long-term methotrexate therapy
Sign Up to like & getrecommendations! Published in 2017 at "Indian Journal of Dermatology, Venereology and Leprology"
DOI: 10.4103/0378-6323.192954
Abstract: 1. Hall RD, Kudchadkar RR. BRAF mutations: Signaling, epidemiology, and clinical experience in multiple malignancies. Cancer Control 2014;21:221-30. 2. Anforth R, Fernandez-Peñas P, Long GV. Cutaneous toxicities of RAF inhibitors. Lancet Oncol 2013;14:e11-8. 3. Dummer… read more here.
Keywords: melanoma; lymphocytic leukemia; metastatic melanoma; chronic lymphocytic ... See more keywords